These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27637184)

  • 1. [Non-muscle-invasive bladder cancer: Information transfer from the clinic to the doctor's office : Results of a questionnaire study and presentation of a software solution].
    Lebentrau S; May M; Weckermann D; Speck T; Wick AK; Mathew M; Schostak M
    Urologe A; 2017 Feb; 56(2):194-201. PubMed ID: 27637184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of a Questionnaire-Based Study on Guideline Adherence Regarding Adjuvant Treatment Recommendations for Patients with Non-Muscle-Invasive Bladder Cancer: Just a Disturbing Sidelight?].
    Lebentrau S; Lebentrau J; May M; Wick AK; Mathew M; Schostak M
    Aktuelle Urol; 2016 Sep; 47(5):408-13. PubMed ID: 27299426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are we following the guidelines on non-muscle invasive bladder cancer?
    Reis LO; Moro JC; Ribeiro LF; Voris BR; Sadi MV
    Int Braz J Urol; 2016; 42(1):22-8. PubMed ID: 27136464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment].
    Neuzillet Y; Colin P; Comperat E; Dubosq F; Houede N; Larre S; Masson-Lecomte A; Pignot G; Puech P; Roumiguie M; Xylinas E; Mejean A; Roupret M
    Prog Urol; 2016 Mar; 26(3):181-90. PubMed ID: 26777686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.
    Nielsen ME; Smith AB; Pruthi RS; Guzzo TJ; Amiel G; Shore N; Lotan Y
    BJU Int; 2012 Oct; 110(7):967-72. PubMed ID: 22487336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
    Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
    Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active surveillance for low-risk non-muscle-invasive bladder cancer: mid-term results from the Bladder cancer Italian Active Surveillance (BIAS) project.
    Hurle R; Pasini L; Lazzeri M; Colombo P; Buffi N; Lughezzani G; Casale P; Morenghi E; Peschechera R; Zandegiacomo S; Benetti A; Saita A; Cardone P; Guazzoni G
    BJU Int; 2016 Dec; 118(6):935-939. PubMed ID: 27207387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-effectiveness analysis of management of low-risk non-muscle-invasive bladder cancer using office-based fulguration.
    Al Hussein Al Awamlh B; Lee R; Chughtai B; Donat SM; Sandhu JS; Herr HW
    Urology; 2015 Feb; 85(2):381-6. PubMed ID: 25623694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study.
    Gontero P; Oderda M; Altieri V; Bartoletti R; Cai T; Colombo R; Curotto A; Di Stasi S; Maffezzini M; Tamagno S; Serretta V; Sogni F; Terrone C; Tizzani A; Morgia G; Mirone V; Carmignani G
    Urol Int; 2011; 86(1):19-24. PubMed ID: 21196690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-muscle invasive bladder cancer: Are epicrises the 'Bermuda Triangle' of information transfer?
    Lebentrau S; May M; Wick AK; Roiner M; Mathew M; Gilfrich C; Schostak M
    Cent European J Urol; 2017; 70(3):245-251. PubMed ID: 29104786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value.
    Fang D; Zhang L; Li X; Yu W; Singla N; Zhao G; Xiong G; Song Y; He Q; He Z; Zhou L
    Ann Surg Oncol; 2015 Aug; 22(8):2789-98. PubMed ID: 25564161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GerOSS (German Obstetric Surveillance System). A Project to Improve the Treatment of Obstetric Rare Diseases and Complications Using a Web Based Documentation and Information Platform.
    Berlage S; Grüßner S; Lack N; Franz HB
    Methods Inf Med; 2015; 54(5):406-11. PubMed ID: 26065375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Biopsy Complications: A Dual Analysis.
    Gaylis F; Nasseri R; Fink L; Calabrese R; Dato P; Cohen E
    Urology; 2016 Jul; 93():135-40. PubMed ID: 27045711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience.
    Iida S; Kondo T; Kobayashi H; Hashimoto Y; Goya N; Tanabe K
    Int J Urol; 2009 Mar; 16(3):287-92. PubMed ID: 19207115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization for transurethral bladder resection reduces quality of life in Danish patients with non-muscle-invasive bladder tumour.
    Mogensen K; Christensen KB; Vrang ML; Hermann GG
    Scand J Urol; 2016 Jun; 50(3):170-4. PubMed ID: 26817989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient satisfaction with and recommendation of a primary care provider: associations of perceived quality and patient education.
    Tung YC; Chang GM
    Int J Qual Health Care; 2009 Jun; 21(3):206-13. PubMed ID: 19258342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.
    Kim SK; Roh YG; Park K; Kang TH; Kim WJ; Lee JS; Leem SH; Chu IS
    Clin Cancer Res; 2014 Jun; 20(12):3233-43. PubMed ID: 24714775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of endoscopic bladder tumour assessment in the management of patients subjected to transurethral bladder tumour resection.
    Skrzypczyk MA; Nyk Ł; Szostek P; Szempliński S; Borówka A; Dobruch J
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26714143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence and progression in non-muscle-invasive bladder cancer using EORTC risk tables.
    Altieri VM; Castellucci R; Palumbo P; Verratti V; Sut M; Olivieri R; Manco R; Ricciardulli S; Nicolai M; Criniti P; Tenaglia RL
    Urol Int; 2012; 89(1):61-6. PubMed ID: 22722366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.